Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

SCAI pushes for better radiation protection in cath labs
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.
Tracking major trends and clinical research in acute coronary syndrome care
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials
Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment.

Amulet vs. Watchman: LAA occluder devices compared in new head-to-head trial

The Amulet's implantation success rate and LAA closure rate were both higher than the first-generation Watchman device, researchers reported.

Ultra-processed foods linked to heart disease, especially among people with unhealthy diets

Researchers tracked data from 2,020 participants who consumed an average of approximately 15 servings of ultra-processed foods per week.

District of Columbia DC congress capitol hill

Imaging advocates, bipartisan lawmakers unite to oppose ‘misguided and massive’ Medicare pay cuts

Congressmen highlighted a planned wage increase for clinical labor that will spell 20% reductions elsewhere, due to budget neutrality.

Edoxaban comparable to VKAs for treating AFib after TAVR

Researchers shared their findings at ESC Congress 2021 and in the New England Journal of Medicine.

Why AFib patients should exercise regularly

Recurrent AFib episodes were much less likely when patients participated in a six-month exercise program.

More than 10% of cardiac arrest patients contacted EMS the day before

These findings indicate that breathing problems may be an underrated warning sign of cardiac arrest, researchers said recently at ESC Congress 2021.

quality imaging appropriateness clinical decision support CAS AUC

Quality experts urge CMS to fold imaging Appropriate Use Criteria Program into other value initiatives

After years of delays, the initiative's usefulness has "diminished significantly," imaging leaders from several noted institutions wrote in Health Affairs.

Consuming large amounts of meat may increase your risk of CVD, heart disease

Researchers tracked data from the UK Biobank study, presenting their findings at ESC Congress 2021.

Cardiology Associations

SCAI pushes for better radiation protection in cath labs

Tracking major trends and clinical research in acute coronary syndrome care

Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves

AI-based coronary plaque evaluations highlight elevated heart risks in women

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials